Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8759 |
High Similarity |
NPD6674 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8272 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8252 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8243 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8112 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD37 |
Approved |
0.8071 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8061 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.805 |
Intermediate Similarity |
NPD4965 |
Approved |
0.805 |
Intermediate Similarity |
NPD4966 |
Approved |
0.805 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8049 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7974 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7963 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7945 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7925 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7808 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7758 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7751 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7718 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7718 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7702 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.764 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7632 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7602 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7566 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7566 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7552 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7552 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7451 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7447 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7434 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD5735 |
Approved |
0.741 |
Intermediate Similarity |
NPD228 |
Approved |
0.7403 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7396 |
Intermediate Similarity |
NPD27 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7357 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7337 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7337 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7324 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7321 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7314 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7292 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7288 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7278 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7266 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7255 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7247 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD4663 |
Approved |
0.723 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7095 |
Approved |
0.717 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7126 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD290 |
Approved |
0.7117 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7076 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7066 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7013 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3060 |
Approved |
0.6994 |
Remote Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6975 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD5929 |
Approved |
0.6959 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD5846 |
Approved |
0.6959 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD1512 |
Approved |
0.6951 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD52 |
Approved |
0.6951 |
Remote Similarity |
NPD7526 |
Approved |
0.6946 |
Remote Similarity |
NPD6072 |
Discontinued |
0.6943 |
Remote Similarity |
NPD6353 |
Approved |
0.6933 |
Remote Similarity |
NPD1774 |
Approved |
0.6928
|
Remote Similarity |
NPD7458 |
Discontinued |